Purine receptors and Ca 2+ signalling in the human blood-brain barrier endothelial cell line hCMEC/D3

Purinergic Signalling

Volumn 8, Issue 1, 2012, Pages 71-80

  Bintig, Willem ^a   Begandt, Daniela ^a   Schlingmann, Barbara ^a,b   Gerhard, Linda ^a   Pangalos, Maria ^a   Dreyer, Lutz ^a   Hohnjec, Natalija ^a   Couraud, Pierre Olivier ^c,d   Romero, Ignacio A ^e   Weksler, Babette B ^f   Ngezahayo, Anaclet ^a,b  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b Center of Systemic Neurosciences (ZSN)   (Germany)

^c INSTITUT COCHIN   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e OPEN UNIVERSITY   (United Kingdom)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

G Protein; Gene silencing; Neurovascular unit; P2 receptors; siRNA

Indexed keywords

1 [[6 (3 METHOXYESTRA 1, 3, 5 (10) TRIEN 17BETA YL) AMINO] HEXYL] 1H PYRROLE 2, 5 DIONE; 2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ALPHA, BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM; COMPLEMENTARY DNA; FURA 2; INOSITOL TRISPHOSPHATE; LIPOFECTAMINE; PHOSPHOLIPASE C; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ARTICLE; BLOOD BRAIN BARRIER; CALCIUM SIGNALING; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84857688640     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9262-7     Document Type: Article

References (42)

1. Drewes LR (2001) Molecular architecture of the brain microvasculature: perspective on blood-brain transport. J Mol Neurosci 16: 93-98.
2. Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53.
3. Banks WA (1999) Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J Neurovirol 6: 538-555.
4. Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10: 1369-1376.
5. del Zoppo GJ (2008) Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 5: S12-S21.
6. Paemeleire K (2002) Calcium signaling in and between brain astrocytes and endothelial cells. Acta Neurol Belg 102: 137-140.
7. del Zoppo GJ (2010) The neurovascular unit in the setting of stroke. J Intern Med 67: 156-171.
8. del Zoppo GJ (2009) Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 158: 972-982.
9. Stolp HB, Dziegielewska KM (2009) Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 35: 132-146.
10. 2 nucleotide receptor-mediated responses in brain cells. Mol Neurobiol 41: 356-366.
11. Lazarowski ER, Harden TK (1999) Quantification of extracellular UTP using a sensitive enzymatic assay. Br J Pharmacol 127: 1272-1278.
12. Xu HL, Pelligrino DA (2007) ATP release and hydrolysis contribute to rat pial arteriolar dilatation elicited by neuronal activation. Exp Physiol 92: 647-651.
13. Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32: 79-87.
14. Pineau I, Lacroix S (2009) Endogenous signals initiating inflammation in the injured nervous system. Glia 57: 351-361.
15. King BF, Townsend-Nicholson A (2003) Nucleotide and nucleoside receptors. Tocris Rev 23: 1-12.
16. von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
17. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
18. Fischer W, Krügel U (2007) P2Y receptors: focus on structural, pharmacological and functional aspects in the brain. Curr Med Chem 14: 2429-2455.
19. Erb L, Liao Z, Seye CI, Weisman GA (2006) P2 receptors: intracellular signaling. Pflugers Arch 452: 552-562.
20. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492.
21. 2+, phospholipase C and mitogen-activated protein kinase. Br J Pharmacol 122: 935-941.
22. Sipos I, Dömötör E, Abbott NJ, Adam-Vizi V (2000) The pharmacology of nucleotide receptors on primary rat brain endothelial cells grown on a biological extracellular matrix: effects on intracellular calcium concentration. Br J Pharmacol 131: 1195-1203.
23. Anwar Z, Albert JL, Gubby SE, Boyle JP, Roberts JA, Webb TE, Boarder MR (1999) Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells. Br J Pharmacol 128: 465-471.
24. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1884.
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
26. Bintig W, Baumgart J, Walter JW, Heisterkamp A, Lubatschowski H, Ngezahayo A (2009) Purinergic signalling in rat GFSHR-17 granulosa cells: an in vitro model of granulosa cells in maturing follicles. J Bioenerg Biomembr 41: 85-94.
27. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
28. Baier MC, Keck M, Gödde V, Niehaus K, Küster H, Hohnjec N (2010) Knockdown of the symbiotic sucrose synthase MtSucS1 affects arbuscule maturation and maintenance in mycorrhizal roots of Medicago truncatula. Plant Physiol 152: 1000-1014.
29. Lazarowski ER, Watt WC, Stutts MJ, Brown HA, Boucher RC, Harden TK (1996) Enzymatic synthesis of UTPγS, a potent hydrolysis resistant agonist of P2U-purinoceptors. Br J Pharmacol 117: 203-209.
30. Brunschweiger A, Müller CE (2006) P2 receptors activated by uracil nucleotides-an update. Curr Med Chem 12: 763-771.
31. Jacobson KA, Ivanov AA, de Castro S, Harden TK, Ko H (2009) Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal 5: 75-89.
32. Jacobson KA, Boeynaems JM (2010) P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 15: 570-578.
33. 6 nucleotide receptors. Biochem Pharmacol 67: 1763-1770.
34. Ullmann H, Meis S, Hongwiset D, Marzian C, Wiese M, Nickel P, Communi D, Boeynaems JM, Wolf C, Hausmann R, Schmalzing G, Kassack MU (2005) Synthesis and structure activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. J Med Chem 48: 7040-7048.
35. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet 21: 115-118.
36. Ouellette M, McDaniel LD, Wright WE, Shay JW, Schultz RA (2000) The establishment of telomerase -immortalized cell line representing human chromosome instability syndromes. Hum Mol Genet 9: 403-411.
37. Poller B, Gutmann H, Krähenbühl S, Weksler B, Romero I, Couraud PO, Tuffin G, Drewe J, Huwyler J (2008) The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 107: 1358-1368.
38. Hansen MR, Krabbe S, Novak I (2008) Purinergic receptors and calcium signalling in human pancreatic duct cell lines. Cell Physiol Biochem 22: 157-168.
39. Burnstock G (2006) Purinergic signalling-an overview. Novartis Found Symp 276: 46-48.
40. Wang L, Karlsson L, Moses S, Hultgårdh-Nilsson A, Andersson M, Borna C, Gudbartsson T, Jern S, Erlinge D (2002) P2 receptor expression profiles in human vascular smooth muscle cells and endothelial cells. J Cardiovasc Pharmacol 40: 841-853.
41. 2 receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling. J Med Chem 52: 2762-2775.
42. von Kügelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn SchmiedebergsArch Pharmacol 362: 310-323.